New MAUDE Report On St. Jude's Durata Leads

Jefferies reported that the Food and Drug Administration Manufacturers and User Facility Device Experience database had a new report on St. Jude Medical Inc.'s (NYSE: STJ) Durata defibrillator leads. The stock price plunged $2.30 to close at $36.24.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here